UTHR Earnings
Latest Revenue783.3M
Latest Net Income333.0M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $7.82 | 783.3M | 333.0M | -1.9% | +14.0% |
| Q1 2026 | $6.32 | 781.5M | 274.9M | -1.6% | -12.0% |
| Q4 2025 | $8.39 | 790.2M | 364.3M | +7.4% | +24.7% |
| Q3 2025 | $7.73 | 799.5M | 338.7M | +6.8% | +11.5% |
| Q2 2025 | $6.86 | 798.6M | 309.5M | +11.7% | +9.6% |
| Q1 2025 | $7.18 | 794.4M | 322.2M | +17.2% | +10.1% |
| Q4 2024 | $6.73 | 735.9M | 301.3M | +19.7% | +46.0% |
| Q3 2024 | $6.93 | 748.9M | 309.1M | +22.9% | +21.4% |
| Q2 2024 | $6.26 | 714.9M | 278.1M | — | — |
| Q1 2024 | $6.52 | 677.7M | 306.6M | — | — |
| Q4 2023 | $4.61 | 614.7M | 217.1M | — | — |
| Q3 2023 | $5.71 | 609.4M | 267.6M | — | — |
United Therapeutics (UTHR) — Earnings